TITLE

Viagra faces stiff competition

AUTHOR(S)
Doonar, Joanna
PUB. DATE
August 2003
SOURCE
Brand Strategy;Aug2003, Issue 174, p26
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Assesses the marketability of the Viagra drug in the British pharmaceutical industry. Increase on the level of competition; Use of branding strategies; Comparison of sales between the year 2002 and 2003. INSET: SPECIAL REPORT: PHARMA.
ACCESSION #
10598772

 

Related Articles

  • Wyeth: Enbrel inflames profits.  // PharmaWatch: Monthly Review;Sep2005, Vol. 4 Issue 9, p22 

    Focuses on Wyeth Pharmaceuticals which has reported a 12% rise in its net revenue because of healthy sales of its arthritis drug Enbrel. Forecasts related to the performance of the drug in the pharmaceutical market; Information on the competition faced by the drug; Reference to the benefit to...

  • Tight belts put squeeze on jobs. Strempel, Dan // Fairfield County Business Journal;9/22/2003, Vol. 42 Issue 38, p1 

    Focuses on the effects of competition on the unemployment rate in Fairfield County, Connecticut. Factors affecting the earnings of various firms; Level of competitive advantage; Number of unemployed workers in the area.

  • Generics Part Two: Diminishing time and opportunity. Thurecht, Norman // Australian Journal of Pharmacy;Feb2012, Vol. 93 Issue 1101, p52 

    The article discusses ways on how pharmacies in Australia can boost their earnings and improve their competitiveness amidst the weighted average price reduction on medicines. It suggests that pharmacies should maximise script throughput and margins via generic substitution and should control...

  • Generic Drug Sales Make Significant Inroads.  // Chemical Market Reporter;6/17/2002, Vol. 261 Issue 24, p6 

    Deals with the concerns raised by the growing sales of generic medicines in Western Europe. Factors attributed to the sales growth; Annual growth rate of generics in various European region; Factors that could influence drug shortage in the region; Effect of the rising generics sales on...

  • Eisai Co (Tokyo JPN) posted a 17% drop in first-half profit because of a slump in sales of Aricept, once the world's best-selling treatment for Alzheimer's disease.  // MondayMorning;11/7/2011, Vol. 19 Issue 40, p1 

    The article reports on the decrease in net profits of Tokyo, Japan-based the pharmaceutical company Eisai Co. Ltd. It states that the decline was due to slump in sales of Aricept, a drug used for the treatment of Alzheimer's disease. It further states that Eisai faced competition from the...

  • Pfizer Feeds Its Drug Habit. Simons, John // Fortune;8/12/2002, Vol. 146 Issue 3, p42 

    Discusses aspects of consolidation in the pharmaceutical industry. Proposed merger of Pfizer and Pharmacia which would make it twice as big as any competitor; Possibility that other companies will merge if the deal succeeds; Opinion that mergers in the pharmaceutical industry will not...

  • Affordable drugs? Forget it! Ranald, Patricia // New Internationalist;Dec2004, Issue 374, p22 

    Focuses on the impact of free trade agreements on the business performance of various pharmaceutical companies in Australia. Increase on the level of competition; Factors affecting the earnings of several firms; Affordability on the prices of the drugs.

  • Novartis Beats Estimates as New Drugs Offset Losses.  // MondayMorning;7/23/2012, Vol. 20 Issue 29, p1 

    The article reports on the financial performance of Novartis AG in 2012. It mentions that the company has gained $3.36 billion in profit, which is due to the increasing sales its Gilenya treatment for multiple sclerosis and Afinitor cancer drug. However, it mentions that the company's profit has...

  • ABBVIE INC.  // MondayMorning;4/29/2013, Vol. 21 Issue 16, p1 

    The article reports on financial performance of the drugmaker AbbVie Inc. in the first quarter of 2013. It mentions that company has earned more profit than expected as its net income was 968 million U.S. dollars while revenue was 4.33 billion U.S. dollars for the same period. It informs that...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics